Literature DB >> 18984468

Disease-specific mechanisms of fibrosis: hepatitis C virus and nonalcoholic steatohepatitis.

David van der Poorten1, Jacob George.   

Abstract

Our mechanistic understanding of liver fibrosis has increased dramatically in recent years for all liver diseases and for hepatitis C and nonalcoholic steatohepatitis (NASH) in particular. Hepatitis C causes liver injury and fibrosis through direct cytopathic means, direct and indirect interactions with hepatic stellate cells, and activation of the immune system. Steatosis and insulin resistance, which are intrinsic deficits in NASH, are also of great importance in hepatitis C and may be induced by viral or host metabolic factors. For NASH, the key mediators of damage include oxidative stress, fat compartmentalization, visceral fat, apoptosis, and adipokine derangement. This article explores in depth the disease-specific mechanisms of fibrosis in hepatitis C and NASH, with a focus on recent developments.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18984468     DOI: 10.1016/j.cld.2008.07.003

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  13 in total

1.  The effect of body weight on the severity and clinical course of ulcerative colitis.

Authors:  Denia Stabroth-Akil; Ludger Leifeld; Roland Pfützer; Julia Morgenstern; Wolfgang Kruis
Journal:  Int J Colorectal Dis       Date:  2014-11-14       Impact factor: 2.571

2.  Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis.

Authors:  Cindy X Cai; Hema Buddha; Shobha Castelino-Prabhu; Zhiwei Zhang; Robert S Britton; Bruce R Bacon; Brent A Neuschwander-Tetri
Journal:  Dig Dis Sci       Date:  2017-02-13       Impact factor: 3.199

Review 3.  microRNAs: fad or future of liver disease.

Authors:  Ashley M Lakner; Herbert L Bonkovsky; Laura W Schrum
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

4.  Strategies Targeting the Innate Immune Response for the Treatment of Hepatitis C Virus-Associated Liver Fibrosis.

Authors:  Daniel Sepulveda-Crespo; Salvador Resino; Isidoro Martinez
Journal:  Drugs       Date:  2021-01-05       Impact factor: 9.546

Review 5.  Vitamin d deficiency in patients with chronic liver disease and cirrhosis.

Authors:  Lei Yuan Lim; Naga Chalasani
Journal:  Curr Gastroenterol Rep       Date:  2012-02

Review 6.  Mechanisms for the Resolution of Organ Fibrosis.

Authors:  Jeffrey C Horowitz; Victor J Thannickal
Journal:  Physiology (Bethesda)       Date:  2019-01-01

7.  p38 mitogen-activated protein kinase and liver X receptor-α mediate the leptin effect on sterol regulatory element binding protein-1c expression in hepatic stellate cells.

Authors:  Kunfeng Yan; Xiong Deng; Xuguang Zhai; Mingming Zhou; Xin Jia; Lin Luo; Minghui Niu; Huixia Zhu; Hui Qiang; Yajun Zhou
Journal:  Mol Med       Date:  2012-02-10       Impact factor: 6.354

8.  Steatosis is a lot more than holes in hepatocytes.

Authors:  Subrata Chakrabarti
Journal:  Saudi J Gastroenterol       Date:  2009-01       Impact factor: 2.485

9.  Hepatitis C virus induces the cannabinoid receptor 1.

Authors:  David van der Poorten; Mahsa Shahidi; Enoch Tay; Jayshree Sesha; Kayla Tran; Duncan McLeod; Jane S Milliken; Vikki Ho; Lionel W Hebbard; Mark W Douglas; Jacob George
Journal:  PLoS One       Date:  2010-09-17       Impact factor: 3.240

Review 10.  Inflammation and liver tumorigenesis.

Authors:  Beicheng Sun; Michael Karin
Journal:  Front Med       Date:  2013-05-17       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.